Youth Destination Logo Final

Bharat Biotech’s intranasal vaccine for COVID-19

Share with Your Friends

Recently, Bharat Biotech has completed the Phase II trial of the intranasal (injected through the nose) Covid vaccine, BBV 154.

It is a novel adeno virus carrier vaccine.

Profit:

Other vaccines only produce antibodies, but intranasal vaccines produce antibodies as well as reduce the risk of infection.

Easy dispensing – no syringe and needle required.

Additional immune response:

  • In addition to immunity in the blood, it also activates the immunity of cells found in the tissues of the nose and mouth and lungs.
  • Only a small amount of this will usually be needed, usually 0.1 ml.

Source – PIB

Download Our App

MORE CURRENT AFFAIRS

Click to Join Our Current Affairs WhatsApp Group

Join Our Whatsapp Group For Daily, Weekly, Monthly Current Affairs Compilation & Daily Mains Answer Writing Test & Current Affairs MCQ

In Our Current Affairs WhatsApp Group you will get daily Mains Answer Writing Question PDF and Word File, Daily Current Affairs PDF and So Much More in Free So Join Now

Register For Latest Notification

Register Yourself For Latest Current Affairs

September 2022
M T W T F S S
« Aug    
 1234
567891011
12131415161718
19202122232425
2627282930  

Mains Answer Writing Practice

Recent Current Affairs (English)

Current Affairs (हिन्दी)

Subscribe Our Youtube Channel

Register now

Get Free Counselling Session with mentor

Download App

Get Youth Pathshala App For Free

Open chat
1
Youth Destination IAS . PCS
To get access
- NCERT Classes
- Current Affairs Magazine
- IAS Booklet
- Complete syllabus analysis
- Demo classes
https://online.youthdestination.in/